Italy, Milan 
Dr. Antonella Cammarota is a medical oncologist and cancer researcher specializing in hepatobiliary and gastrointestinal malignancies. Her work focuses on immune response biomarkers in biliary tract cancers, with a strong emphasis on translational research and early-phase clinical trials.
Current Position
- Medical Oncologist and Cancer Researcher, Lleo Lab, Humanitas Research Hospital
- AIRC Postdoctoral Fellow
Education
- Specialist in Medical Oncology, Humanitas Research Hospital (2023)
- MD, Università Cattolica del Sacro Cuore, Rome, Italy (2017, with honors)
Area of Specialization
- Gastrointestinal and hepatobiliary cancers
- Biliary tract tumors
- Tumor immune microenvironment and biomarkers
- Translational oncology research
- Early-phase clinical trials (Phase I–III)
Professional Experience
- Sub-investigator in multiple Phase 1–3 clinical trials, Sarah Cannon Research Institute, London (since 2022)
- Development of novel therapeutics for gastrointestinal tumors
- Led educational program on early-phase clinical trials
- Designed biomarker-driven study selected for MCCR 2023
Research & Scientific Activity
- Translational research at University of Cambridge
- Expertise in:Immunohistochemistry
- Immunofluorescence
- Computational image analysis
- Bioinformatics
- Research focused on immune biomarkers in hepatobiliary tumors
Leadership & Memberships
Co-Chair, EORTC Young Investigator GI Task Force (since 2024)
Publications & Scientific Output
- Author of 20+ peer-reviewed publications
- Contributor to book chapters and conference abstracts/posters
- Presenter at major international congresses including:ESMO
- ESMO WGI
- ESMO Asia
- AUGIS
Awards & Grants
- EORTC Young Early-Career Investigator Grant (2023)
- AIRC Fellowship (2024)
- ESMO Merit Travel Grants and other educational awards
All information is sourced from publicly available materials.